chronic pancreatitis recurrent pancreatitis alcoholic acute pancreatitis
Conditions
Interventions
1 tablet of Foipan to be taken three times a day (300mg/day) after meals for 21 months, following 2 tablets of Foipan three times a day (600mg/day) for 3 months.
1 gram of Berizym (granules) to be ta
Sponsors
Tohoku University Graduate School of Medicine Division of Gastroenterology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who recieved hospital treatment for recurrent pancreatitis or acute exacerbation of chronic pancreatitis. Outpatients with chronic pancreatitis. Patients with alcoholic acute pancreatitis.
Exclusion criteria
Exclusion criteria: 1) Patients under 20 years old. 2) Patients with contraindications to Foipan or Berizym. 3) Patients scheduled for surgery, endoscopic treatment, or extracorporeal shock wave lithotripsy(ESWL) as treatment for pancreatitis. 4) Patients whom the attending doctor consider inappropiate to participate in this clinical study for some reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| frequency of pancreatitis attacks | — |
Secondary
| Measure | Time frame |
|---|---|
| quality of life glucose tolerance pancreatic exocrine function pancreatic fibrosis pancreatic inflammation | — |
Countries
Japan
Contacts
Public ContactAtsushi Masamune
Tohoku University Graduate School of Medicine Division of Gastroenterology
Outcome results
None listed